Mauna Kea Technologies SAS (MKEA):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Mauna Kea Technologies SAS (MKEA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7291
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mauna Kea Technologies SAS (MKT) is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides confocal laser endomicroscopy platform. MKT’s cellvizio is an endomicroscopy platform that provides microscopic images of tissue instantaneously and in a minimally-invasive way. The company also offers vasculature and vasodynamics studies, longitudinal monitoring of disease progression and in vivo histology. It provides technical support and training. MKT’s products are used for treatment of digestive diseases and diagnosing respiratory diseases and also used in laboratories for research on small animals. The company has presence in North America, Europe and Asia. MKT is headquartered in Paris, France.

Mauna Kea Technologies SAS (MKEA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Mauna Kea Technologies SAS, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Mauna Kea Technologies SAS, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Mauna Kea Technologies SAS, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Mauna Kea Technologies SAS, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Mauna Kea Technologies SAS, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Mauna Kea Technologies SAS, Medical Equipment, Deal Details 11
Partnerships 11
Edinburgh Molecular Imaging Enters into Partnership with Mauna Kea Technologies 11
Mauna Kea Enters into Distribution Agreement with Cook Medical 12
Mauna Kea Technologies Enters Into Co-Development With Imperial College London 13
Mauna Kea Technologies Expands Agreement with Fujifilm China Investment for Cellvizio 14
Mauna Kea Technologies Enters Into Co-Development Agreement With University of Edinburgh And Edinburgh BioQuarter 15
Equity Offering 16
Mauna Kea Technologies to Raise USD9.1 Million in Public Offering of Shares 16
Mauna Kea Technologies to Raise USD5.7 Million in Public Offering of Shares 17
Mauna Kea Technologies Raises USD4.9 Million in Private Placement of Shares 18
Mauna Kea Raises USD5 Million in Private Placement Shares 20
Mauna Kea to Raise USD7.4 Million in Private Placement of Shares 21
Debt Offering 22
Mauna Kea Tech Raises USD4.3 Million in First Tranche of Private Placement of Bonds Due 2022 22
Acquisition 23
French, European, and American Investors Acquire Stake in Mauna Kea Technologies 23
Mauna Kea Technologies SAS – Key Competitors 24
Mauna Kea Technologies SAS – Key Employees 25
Mauna Kea Technologies SAS – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Sep 20, 2018: Mauna Kea Technologies reports first half 2018 financial results 27
Sep 20, 2017: Mauna Kea Technologies Reports First Half 2017 Financial Results 29
Jul 25, 2017: Mauna Kea Technologies Reports First Half 2017 Sales 31
Apr 19, 2017: Mauna Kea Technologies Reports First Quarter 2017 Sales 32
Mar 23, 2017: Mauna Kea Technologies Reports Full Year 2016 Financial Results And Highlights 2017 Key Priorities 33
Jan 24, 2017: Mauna Kea Technologies Reports Fourth Quarter and Full Year 2016 Sales 35
Corporate Communications 36
Apr 05, 2018: Appointment of Christophe Lamboeuf to the position of Chief Financial Officer 36
Jan 15, 2018: Mauna Kea Technologies Appoints Experienced Healthcare Executive, Molly O’Neill, to Board of Directors 37
Oct 17, 2017: Mauna Kea Technologies Appoints Olivier Regnard as Deputy CEO And Chief Financial Officer 38
Mar 13, 2017: Mauna Kea Appoints Jennifer F. Tseng, M.D. to Board of Directors 39
Product News 40
Sep 13, 2018: Mauna Kea Technologies introduces its needle-based cellvizio endomicroscopy solution for applications in lung cancer and other pulmonary diseases 40
May 31, 2018: Mauna Kea Technologies Announces 20 Presentations Highlighting Cellvizio’s Clinical Value in Evaluating IBDs and Pancreatic Cysts at DDW 2018 42
Aug 31, 2017: Mauna Kea Technologies Announces Strong Presence of Cellvizio at the OESO 14th World Conference 44
Aug 02, 2017: Mauna Kea Technologies Announces Peer-Reviewed Publication of Key Multicenter Randomized Controlled Trial Demonstrating Improved Early Stomach Cancer Detection with Cellvizio 45
May 23, 2017: Mauna Kea Technologies Announces the Presentation of New Data Demonstrating the Assessment by Cellvizio of Acute Lung Rejection Following Transplant 46
Apr 03, 2017: Mauna Kea Technologies: Largest Cellvizio Study To Date Demonstrates Near Perfect Correlation with Histology in Key GI Procedures 47
Mar 27, 2017: Mauna Kea Technologies: New Peer-Reviewed Publication Reports Further External Validation of Unmatched Cellvizio Endomicroscopy Performance 48
Mar 02, 2017: Mauna Kea Technologies: Superiority of Endomicroscopy for the Diagnosis of Gastric Cancer Highlighted in a Peer-Reviewed Publication Comparing Advanced Imaging Technologies 49
Other Significant Developments 50
Jul 25, 2018: Mauna Kea Technologies Reports Second Quarter and First Half 2018 Sales 50
Nov 16, 2017: Mauna Kea Technologies Announces Reimbursement Coverage for Cellvizio in Croatia 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
Mauna Kea Technologies SAS, Medical Equipment, Key Facts, 2017 2
Mauna Kea Technologies SAS, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Mauna Kea Technologies SAS, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Mauna Kea Technologies SAS, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Mauna Kea Technologies SAS, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Mauna Kea Technologies SAS, Deals By Market, 2012 to YTD 2018 9
Mauna Kea Technologies SAS, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Edinburgh Molecular Imaging Enters into Partnership with Mauna Kea Technologies 11
Mauna Kea Enters into Distribution Agreement with Cook Medical 12
Mauna Kea Technologies Enters Into Co-Development With Imperial College London 13
Mauna Kea Technologies Expands Agreement with Fujifilm China Investment for Cellvizio 14
Mauna Kea Technologies Enters Into Co-Development Agreement With University of Edinburgh And Edinburgh BioQuarter 15
Mauna Kea Technologies to Raise USD9.1 Million in Public Offering of Shares 16
Mauna Kea Technologies to Raise USD5.7 Million in Public Offering of Shares 17
Mauna Kea Technologies Raises USD4.9 Million in Private Placement of Shares 18
Mauna Kea Raises USD5 Million in Private Placement Shares 20
Mauna Kea to Raise USD7.4 Million in Private Placement of Shares 21
Mauna Kea Tech Raises USD4.3 Million in First Tranche of Private Placement of Bonds Due 2022 22
French, European, and American Investors Acquire Stake in Mauna Kea Technologies 23
Mauna Kea Technologies SAS, Key Competitors 24
Mauna Kea Technologies SAS, Key Employees 25
Mauna Kea Technologies SAS, Subsidiaries 26

List of Figures
Mauna Kea Technologies SAS, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Mauna Kea Technologies SAS, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Mauna Kea Technologies SAS, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Mauna Kea Technologies SAS, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Mauna Kea Technologies SAS, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Mauna Kea Technologies SAS, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Mauna Kea Technologies SAS, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Mauna Kea Technologies SAS, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Mauna Kea Technologies SAS (MKEA):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AbGenomics International Inc-製薬・医療分野:企業M&A・提携分析
    Summary AbGenomics International Inc (AbGenomics) is a biopharmaceutical company that develops therapeutics for inflammatory diseases and cancers. The company provides products such as pipeline products, monoclonal antibody products, therapeutic products, neihulizumab, bio-therapeutics, and biobette …
  • Cheng Loong Corp:企業の戦略・SWOT・財務情報
    Cheng Loong Corp - Strategy, SWOT and Corporate Finance Report Summary Cheng Loong Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Photocure ASA (PHO):企業の財務・戦略的SWOT分析
    Photocure ASA (PHO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Swedish Orphan Biovitrum AB (SOBI):企業の財務・戦略的SWOT分析
    Swedish Orphan Biovitrum AB (SOBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Sebia SA:企業の製品パイプライン分析2018
    Summary Sebia SA (Sebia) is a medical device company that designs, manufactures, commercializes, and exports electrophoresis tests and analyzers. The company's electrophoresis program offers automated system for capillary electrophoresis, gel electrophoresis and electrophoresis scanning software. It …
  • Kolorfusion International Inc:企業の戦略的SWOT分析
    Kolorfusion International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Toyobo Co Ltd (3101):企業の財務・戦略的SWOT分析
    Toyobo Co Ltd (3101) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Shimano Inc (7309):企業の財務・戦略的SWOT分析
    Shimano Inc (7309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • European Institute of Oncology:製薬・医療:M&Aディール及び事業提携情報
    Summary European Institute of Oncology (IEO) is a research institute that conducts clinical and scientific research on cancer prevention, early diagnosis and treatment of cancer. The institute offers medical care services for breast tumors, lung tumors, cervical tumors, endometrial tumors, thoracic …
  • JEA:企業の戦略的SWOT分析
    JEA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up- …
  • PT. Millennium Pharmacon International TBK (SDPC):企業の財務・戦略的SWOT分析
    PT. Millennium Pharmacon International TBK (SDPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • MonTa Biosciences ApS:製薬・医療:M&Aディール及び事業提携情報
    Summary MonTa Biosciences ApS (MonTa Biosciences) is a biotechnology company that develops and commercializes immuno-oncology therapeutics for cancer therapy. Its pipeline products include MBS2, and MBS5 used for the treatment of cancer and infectious diseases. The company’s technology is based on T …
  • Molex LLC:企業のM&A・事業提携・投資動向
    Molex LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Molex LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Paratek Pharmaceuticals Inc (PRTK):製薬・医療:M&Aディール及び事業提携情報
    Summary Paratek Pharmaceuticals Inc (Paratek) is a biopharmaceutical company that develops and commercializes therapies based on tetracycline chemistry. Omadacycline (antibiotic), the company’s lead product candidate is an aminomethylcycline which acts against gram-negative, gram-positive, and atypi …
  • Electric Power Industry of Serbia:企業の戦略的SWOT分析
    Electric Power Industry of Serbia - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Cascade Metrix LLC:製品パイプライン分析
    Summary Cascade Metrix LLC (CMI) is a medical technology company that commercializes an automated POC blood analyzer for critical care. The company provides product portfolio such as novel micro-volume IV extension kits; and automated glucose monitoring systems, among others. It also provides a revo …
  • CitiPower and Powercor:企業の戦略的SWOT分析
    CitiPower and Powercor - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • BioChain Institute Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioChain Institute Inc (BioChain) is a medical device company that designs, develops and markets diagnostic products. The company offers processed bio-sample products and analysis services used in translational medicine, companion diagnostics, and clinical product research and development. I …
  • ALK-Abello AS (ALK B)-製薬・医療分野:企業M&A・提携分析
    Summary ALK-Abello A/S (ALK) is a research-oriented pharmaceutical company, which discovers, develops and commercializes immunotherapies for allergy prevention and treatment. It also markets diagnostics and other services to allergy clinics. The company's allergy immunotherapy product portfolio incl …
  • Immunodiagnostic Systems Holdings plc (IDH)-医療機器分野:企業M&A・提携分析
    Summary Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research area …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆